Author Correction: Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation
Hidetaka Uryu(The University of Texas MD Anderson Cancer Center), Koichi Takahashi(The University of Texas MD Anderson Cancer Center), Ken Furudate(The University of Texas MD Anderson Cancer Center), Michael Spencer Chapman(Wellcome Sanger Institute), Carlos E. Bueso‐Ramos(The University of Texas MD Anderson Cancer Center), Courtney D. DiNardo(The University of Texas MD Anderson Cancer Center), Linda Zhang(Baylor College of Medicine), Koichi Saeki(Tokyo University of Science), Satoko Ogata(The University of Texas MD Anderson Cancer Center), Muzaffar H. Qazilbash(The University of Texas MD Anderson Cancer Center), Shujuan Chen(University of California San Diego), Nitin Jain(The University of Texas MD Anderson Cancer Center), Xingzhi Song(The University of Texas MD Anderson Cancer Center), Gheath Alatrash(The University of Texas MD Anderson Cancer Center), Elizabeth Shpall(The University of Texas MD Anderson Cancer Center), Hui Yang(Fudan University), Naval Daver(The University of Texas MD Anderson Cancer Center), Robert Z. Orlowski(University of North Carolina at Chapel Hill), Erika J. Thompson(The University of Texas MD Anderson Cancer Center), Chiraag D. Kapadia(Baylor College of Medicine), Simona Colla(The University of Texas MD Anderson Cancer Center), Hongli Tang(The University of Texas MD Anderson Cancer Center), Jeffery Molldrem(The University of Texas MD Anderson Cancer Center), Daisuke Nakada(Baylor College of Medicine), Rashmi Kanagal‐Shamanna(The University of Texas MD Anderson Cancer Center), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), P. Andrew Futreal(The University of Texas MD Anderson Cancer Center), Joanne I. Hsu(Harvard University), Jennifer Padilla(Baylor College of Medicine), Sarah Hanache(The University of Texas MD Anderson Cancer Center), Margaret A. Goodell(Baylor College of Medicine), Kapil N. Bhalla(University of South Florida), Zongrui Li(The University of Texas MD Anderson Cancer Center), Hiroshi Haeno(Tokyo University of Science), Jyoti Nangalia(University of Namur), Chong Zhao(The University of Texas MD Anderson Cancer Center), Naveen Pemmaraju(The University of Texas MD Anderson Cancer Center), Curtis Gumbs(The University of Texas MD Anderson Cancer Center), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Latasha Little(The University of Texas MD Anderson Cancer Center), Farhad Ravandi(The University of Texas MD Anderson Cancer Center), Jianhua Zhang(WiCell), Tomoyuki Tanaka(Chiba University)
Cited by 1
Related Papers
The cancer genome
|Nature|2009|3.5k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
|Nucleic Acids Research|2010|2.3k